Cost and cost-effectiveness analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis
Nkgomeleng Lekodeba, Katherine Snyman, View ORCID ProfileBrooke E Nichols, Lise Jamieson
doi: https://doi.org/10.1101/2024.12.13.24319006
Nkgomeleng Lekodeba
aHealth Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Katherine Snyman
aHealth Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
bDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom
Brooke E Nichols
cDepartment of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA
dDepartment of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Lise Jamieson
aHealth Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
eSouth African Department of Science and Innovation/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa
Article usage
Posted December 14, 2024.
Cost and cost-effectiveness analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis
Nkgomeleng Lekodeba, Katherine Snyman, Brooke E Nichols, Lise Jamieson
medRxiv 2024.12.13.24319006; doi: https://doi.org/10.1101/2024.12.13.24319006
Cost and cost-effectiveness analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis
Nkgomeleng Lekodeba, Katherine Snyman, Brooke E Nichols, Lise Jamieson
medRxiv 2024.12.13.24319006; doi: https://doi.org/10.1101/2024.12.13.24319006
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2939)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4582)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4350)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6935)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)